| Dose level | Dose of drug: SGN‐2FF | Dose of drug: Pembrolizumab | Number enrolled | Number evaluable for toxicity |
|---|---|---|---|---|
| 1 | 2 g QD | 200 mg every 21 days | 4 | 4 |
| 2 | 5 g QD | 200 mg every 21 days | 3 | 3 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.